• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cumberland Pharmaceuticals Inc. - Common Stock (NQ:CPIX)

    5.510 -0.020 (-0.36%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cumberland Pharmaceuticals Inc. - Common Stock

    < Previous 1 2 3 4 Next >
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    Cumberland (CPIX) Q4 2025 Earnings Call Transcript ↗
    Cumberland (CPIX) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For August 5, 2025 ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For May 6, 2025 ↗
     
    Via Benzinga
    News headline image
    CPIX Stock Earnings: Cumberland Reported Results for Q1 2024 ↗
    Cumberland just reported results for the first quarter of 2024. 
    Via InvestorPlace
    News headline image
    CPIX Stock Earnings: Cumberland Reported Results for Q4 2023 ↗
    Cumberland just reported results for the fourth quarter of 2023. 
    Via InvestorPlace
    News headline image
    Cumberland (CPIX) Q2 Revenue Up 10% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For March 4, 2025 ↗
     
    Via Benzinga
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-02-19: top gainers and losers in today's session. ↗
    Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
    Via Chartmill
    News headline image
    Here are the top movers in Wednesday's session. ↗
    Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
    Via Chartmill
    News headline image
    What's going on in today's session ↗
    Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
    Via Chartmill
    News headline image
    What's going on in today's after hours session ↗
    The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
    Via Chartmill
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session. ↗
    Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
    Via Chartmill
    News headline image
    Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease ↗
    Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients. 
    Via Benzinga
    News headline image
    Discover the top movers in Tuesday's pre-market session. ↗
    Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings ↗
     
    Via Benzinga
    Topics Stocks
    News headline image
    Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings ↗
     
    Via Benzinga
    News headline image
    Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday? ↗
    FDA approval streamlines Acetadote dosing, enhancing safety and efficiency in treating acetaminophen-related liver injury in hospitals worldwide. 
    Via Benzinga
    News headline image
    Dow Falls 150 Points; Oracle Posts Downbeat Results ↗
     
    Via Benzinga
    Topics Stocks
    News headline image
    Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
    Gainers 
    Via Benzinga
    News headline image
    Earnings Scheduled For March 5, 2024 ↗
    Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
    Via Benzinga
    News headline image
    Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket ↗
    Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales. 
    Via Benzinga
    News headline image
    Caldolor: The Only Non-Opioid Injectable Pain Reliever Approved for Use in Infants, Says FDA ↗
    The FDA has approved expanded labeling for Cumberland Pharmaceuticals Inc's (NASDAQ: CPIX) Caldolor, an intravenously delivered formulation of ibuprofen,  
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.